Asthma control and medication adherence among asthmatic outpatients in Vietnam: A cross-sectional study

Q4 Pharmacology, Toxicology and Pharmaceutics
Sang Thanh Huynh, Ngoc Viet Nguyen, Ho Nhu Nguyen
{"title":"Asthma control and medication adherence among asthmatic outpatients in Vietnam: A cross-sectional study","authors":"Sang Thanh Huynh, Ngoc Viet Nguyen, Ho Nhu Nguyen","doi":"10.29090/psa.2022.02.21.186","DOIUrl":null,"url":null,"abstract":"Suboptimal asthma control and medication non-adherence are common and associated with adverse disease outcomes. This study aimed to assess the medication adherence, level of asthma control, and determine factors associated with asthma control among asthmatic outpatients. A cross-sectional study was conducted on 250 asthmatic patients aged  12 visiting the Asthma Management Clinic at a tertiary hospital in Vietnam from April to June 2019. Data, including demographics, medication treatment and adherence, and asthma control, were collected through structured interviews and prescription review. Asthma control and medication adherence were measured using the Asthma Control Test (ACT) questionnaire and the Morisky Medication Adherence Scale 8-items (MMAS-8), respectively. Multivariable logistic regression analysis was used to determine the associated factors with asthma control. The mean age of the study participants was 59.1 years and the majority were women (67.2%). All patients were using inhaled corticosteroid (ICS)-containing controller therapy. The proportion of patients highly adhering to prescribed medications was 34.4%. Well-controlled asthma was observed in 64.4% of patients. Age group of  60 (aOR=3.43, 95%CI 1.21-9.68), low medication adherence (aOR=2.97, 95%CI 1.40-6.30), and using medium or high dose of ICS (aOR=3.38, 95%CI 1.64-6.97; aOR=4.28, 95%CI 1.90-9.65, respectively) were associated with poorly-controlled asthma. Poorly controlled asthma was still prevalent. Patient’s age, medication adherence, and ICS dosage are some factors which healthcare providers should consider when asthma control was under expectation.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2022.02.21.186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Suboptimal asthma control and medication non-adherence are common and associated with adverse disease outcomes. This study aimed to assess the medication adherence, level of asthma control, and determine factors associated with asthma control among asthmatic outpatients. A cross-sectional study was conducted on 250 asthmatic patients aged  12 visiting the Asthma Management Clinic at a tertiary hospital in Vietnam from April to June 2019. Data, including demographics, medication treatment and adherence, and asthma control, were collected through structured interviews and prescription review. Asthma control and medication adherence were measured using the Asthma Control Test (ACT) questionnaire and the Morisky Medication Adherence Scale 8-items (MMAS-8), respectively. Multivariable logistic regression analysis was used to determine the associated factors with asthma control. The mean age of the study participants was 59.1 years and the majority were women (67.2%). All patients were using inhaled corticosteroid (ICS)-containing controller therapy. The proportion of patients highly adhering to prescribed medications was 34.4%. Well-controlled asthma was observed in 64.4% of patients. Age group of  60 (aOR=3.43, 95%CI 1.21-9.68), low medication adherence (aOR=2.97, 95%CI 1.40-6.30), and using medium or high dose of ICS (aOR=3.38, 95%CI 1.64-6.97; aOR=4.28, 95%CI 1.90-9.65, respectively) were associated with poorly-controlled asthma. Poorly controlled asthma was still prevalent. Patient’s age, medication adherence, and ICS dosage are some factors which healthcare providers should consider when asthma control was under expectation.
越南哮喘门诊患者的哮喘控制和药物依从性:一项横断面研究
次优哮喘控制和药物依从性不佳是常见的,并与不良疾病结局相关。本研究旨在评估哮喘门诊患者的药物依从性、哮喘控制水平,并确定与哮喘控制相关的因素。对2019年4 - 6月在越南某三级医院哮喘管理门诊就诊的250例12岁哮喘患者进行横断面研究。数据,包括人口统计,药物治疗和依从性,哮喘控制,通过结构化访谈和处方审查收集。分别采用哮喘控制测试(ACT)问卷和Morisky药物依从性量表8项(MMAS-8)测量哮喘控制性和药物依从性。采用多变量logistic回归分析确定哮喘控制的相关因素。研究参与者的平均年龄为59.1岁,大多数是女性(67.2%)。所有患者均采用吸入性皮质类固醇(ICS)控制疗法。遵医嘱比例为34.4%。64.4%的患者哮喘控制良好。年龄≥60岁(aOR=3.43, 95%CI 1.21 ~ 9.68)、低药物依从性(aOR=2.97, 95%CI 1.40 ~ 6.30)、使用中、高剂量ICS (aOR=3.38, 95%CI 1.64 ~ 6.97;aOR=4.28, 95%CI分别为1.90 ~ 9.65)与哮喘控制不良相关。控制不良的哮喘仍然很普遍。患者的年龄、药物依从性和ICS剂量是医疗保健提供者在期望哮喘控制时应该考虑的一些因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutical Sciences Asia
Pharmaceutical Sciences Asia Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍: The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信